Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics 
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Purinergic (P2X) Receptors
More Information »P2X receptors are members of the ligand-gated ion channel family that open in response to extracellular ATP. Each receptor is made up of a trimer of subunits (P2X1-7) all of which share the common structure of two transmembrane domains.
Purinergic (P2X) Receptors Products
Agonists |
|
Cat.No. |
Product Name / Activity |
| 3245 | ATP disodium salt |
| P2 purinergic agonist | |
| 4080 | ATPγS tetralithium salt |
| P2 agonist; ATP (Cat. No. 3245) analog | |
| 3312 | BzATP triethylammonium salt |
| P2X7 agonist. Also P2X1 and P2Y1 partial agonist | |
| 3209 | α,β-Methyleneadenosine 5'-triphosphate trisodium salt |
| P2-purinoceptor agonist | |
| 1062 | 2-Methylthioadenosine triphosphate tetrasodium salt |
| P2 purinergic agonist | |
Antagonists |
|
Cat.No. |
Product Name / Activity |
| 2972 | A 438079 hydrochloride |
| Competitve P2X7 antagonist | |
| 3701 | A 740003 |
| Potent and selective P2X7 antagonist | |
| 4473 | A 804598 |
| Potent and selective P2X7 antagonist | |
| 4232 | A 839977 |
| Potent P2X7 antagonist | |
| 3323 | AZ 10606120 dihydrochloride |
| Potent P2X7 receptor antagonist | |
| 3317 | AZ 11645373 |
| Potent and selective human P2X7 antagonist | |
| 3579 | 5-BDBD |
| Potent P2X4 receptor antagonist | |
| 0845 | Evans Blue tetrasodium salt |
| Selective P2X purinergic antagonist | |
| 1277 | KN-62 |
| Non-competitive P2X7 antagonist | |
| 1240 | NF 023 |
| Selective, competitive P2X1 antagonist | |
| 2548 | NF 110 |
| Potent P2X3 antagonist | |
| 2450 | NF 157 |
| Selective P2Y11/P2X1 antagonist | |
| 1199 | NF 279 |
| Potent and selective P2X1 antagonist | |
| 1391 | NF 449 |
| Highly selective P2X1 antagonist | |
| 0625 | PPADS tetrasodium salt |
| P2 purinergic antagonist | |
| 0683 | iso-PPADS tetrasodium salt |
| P2X antagonist | |
| 1309 | PPNDS |
| Potent, selective P2X1 antagonist | |
| 2188 | Ro 0437626 |
| Selective P2X1 antagonist | |
| 4391 | Ro 51 |
| Potent P2X3, P2X2/3 antagonist | |
| 3052 | RO-3 |
| Selective P2X3 and P2X2/3 antagonist | |
| 2931 | Spinorphin |
| Potent P2X3 antagonist | |
| 1472 | Suramin hexasodium salt |
| Non-selective P2 antagonist | |
| 4386 |
TC-P 262
|
| Selective P2X3, P2X2/3 antagonist | |
| 2464 | TNP-ATP triethylammonium salt |
| Potent, selective P2X antagonist | |
Modulators |
|
Cat.No. |
Product Name / Activity |
| 3385 | GW 791343 hydrochloride |
| P2X7 allosteric modulator | |
| 1260 | Ivermectin |
| Positive allosteric modulator for P2X4 receptor | |
Other |
|
Cat.No. |
Product Name / Activity |
| 1203 | MRS 2219 |
| Potentiates P2X1-mediated responses | |
Related Categories
Quick Order
Find multiple products by catalog number
Pain Research Guide
Reserve your free copy
Highlights over 280 products for Pain research. Reserve copy
P2 Receptors Review
Written by Kenneth Jacobson, an expert in the field. Request a copy or view PDF today.
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.